Table 3.
HZ adjusted relative risk for COPD and COPD-ICS patients in relation with Non-COPD
| Relative Risk (95% CrI) | ||
|---|---|---|
| COPD | NO COPD | 1 |
| COPD | 1.45 (1.41–1.5) | |
| COPD-ICS | 1.61 (1.52–1.71) | |
| Sex | Male | 1 |
| Female | 1.36 (1.33–1.38) | |
| Age | 50–59 | 1 |
| (Years) | 60–69 | 1.38 (1.34–1.41) |
| 70–79 | 1.53 (1.49–1.57) | |
| 80_+ | 1.49 (1.45–1.54) | |
| Comorbidity | ||
| Diabetes | No Diabetes | 1 |
| Diabetes | 1.2 (1.17–1.22) | |
| HF | No HF | 1 |
| HF | 1.25 (1.2–1.3) | |
Relative risk estimates and 95% credible intervals (95% CrI) for the association between HZ incidence and COPD, controlling for sex, age, comorbidities (Diabetes and HF), health department (as a random effect) and calendar year, using Bayesian Poisson regression